Evidence map›Paper›PMID 28983240›Full record

ArticleFrontiers in molecular neuroscience2017

Transcription Factor NFAT5 Promotes Glioblastoma Cell-driven Angiogenesis via SBF2-AS1/miR-338-3p-Mediated EGFL7 Expression Change.

Hai Yu, Jian Zheng, Xiaobai Liu, Yixue Xue, Shuyuan Shen, Lini Zhao, Zhen Li, Yunhui Liu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. The Roles Played by Long Non-Coding RNAs in Glioma Resistance.International journal of molecular sciences · 2021
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Hai YuDepartment of Neurosurgery, Shengjing Hospital of China Medical UniversityShenyang, China.
Jian ZhengDepartment of Neurosurgery, Shengjing Hospital of China Medical UniversityShenyang, China.
Xiaobai LiuDepartment of Neurosurgery, Shengjing Hospital of China Medical UniversityShenyang, China.
Yixue XueDepartment of Neurobiology, College of Basic Medicine, China Medical UniversityShenyang, China.
Shuyuan ShenDepartment of Neurobiology, College of Basic Medicine, China Medical UniversityShenyang, China.
Lini ZhaoDepartment of Neurobiology, College of Basic Medicine, China Medical UniversityShenyang, China.
Zhen LiDepartment of Neurosurgery, Shengjing Hospital of China Medical UniversityShenyang, China.
Yunhui LiuDepartment of Neurosurgery, Shengjing Hospital of China Medical UniversityShenyang, China.
China Medical University · CNMinistry of Education of the People's Republic of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioblastoma (GBM) is the most aggressive primary intracranial tumor of adults and confers a poor prognosis due to high vascularization. Hence anti-angiogenic therapy has become a promising strategy for GBM treatment. In this study, the transcription factor nuclear factor of activated T-cells 5 (NFAT5) was significantly elevated in glioma samples and GBM cell lines, and positively correlated with glioma WHO grades. Knockdown of

Indexed as

EGFL7glioblastoma angiogenesislong non-coding RNAmiR-338-3pNFAT5SBF2-AS1transcription factor

Identifiers

PMID28983240
PMCPMC5613209
OpenAlexW2756099564

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.